Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBOS Group.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
Health & Biotech
ASX Health Stocks: Healthcare index surges as CSL revels in blood plasma boom
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
Health & Biotech
ASX Health Stocks: Aussie biotechs Argenica and Antisense take major steps in the US
News
Here are the top ASX large cap movers for Wednesday
Health & Biotech
ScoPo’s Powerplays: Recent price swings uncovered hidden gems and buying opportunities in healthcare
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Experts
Scopo’s powerplays: Investors love an ice queen
Experts
Scopo’s health powerplays: Health goes up when markets go down
News
